Literature DB >> 6617079

The presentation haemoglobin level in 1103 patients with Hodgkin's disease (BNLI report no. 21).

K A MacLennan, B Vaughan Hudson, M J Easterling, A M Jelliffe, G Vaughan Hudson, J L Haybittle.   

Abstract

The presentation haemoglobin level was measured in 1103 patients with Hodgkin's disease. A reduced presentation haemoglobin level occurred with a higher relative frequency in patients with advanced disease, systemic (B) symptoms and aggressive histological subtypes. A reduced presentation haemoglobin was associated with a decreased survival.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617079     DOI: 10.1016/s0009-9260(83)80146-9

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  2 in total

1.  Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma.

Authors:  C C Anderson; A H Goldstone; R L Souhami; D C Linch; P G Harper; K A McLennan; M Jones; S J Machin; A M Jelliffe; J C Cawley
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model.

Authors:  Fatemeh Javanmardi; Amal Saki-Malehi; Ahmad Ahmadzadeh; Fakher Rahim
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2018-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.